Skip to main content
. 2022 Sep 2;76(3):487–496. doi: 10.1093/cid/ciac714

Table 3.

Inverse Propensity Weighting Comparisons of Primary Endpoint (Microbiologic Failure at 90 d) by Antibiotics Strategy

Comparison Groups A
Completed Inpatient IV [Gold standard]
B
Partial IV, No Oral
C
Partial IV, Partial Oral
P Value
Comparing microbiologic failure at 90 d between patients who discharged before completing IV antibiotics (strategy B vs C) 16 (44.4)
[N = 36]
9 (13.0)
[N = 69]
.001
- Inverse probability weighted aOR 6.7 (1.9, 25.8) 1 (reference) .005
Comparing microbiologic failure at 90 d between patients who completed standard of care (strategy A) vs partial oral antibiotics (strategy C) 13 (10.7)
[N = 122]
9 (13.0)
[N = 69]
.8
- Inverse probability weighted 1 (reference) aOR 1.3 (0.4, 3.7) .7
Subgroup analysis: Including only those with ≥10 d effective IV antibiotic therapy before discharge
Comparing microbiologic failure at 90 d between patients who discharged before completing IV antibiotics (strategy B vs C) 9 (40.9)
[N = 22]
5 (10.9)
[N = 46]
.004
- Inverse probability weighted aOR 5.4 (1.2, 24.0) 1 (reference) .03
Comparing microbiologic failure at 90 d between patients who completed standard of care (strategy A) vs partial oral antibiotics (strategy C) 13 (10.7)
[N = 122]
5 (10.9)
[N = 46]
.9
- Inverse probability weighted 1 (reference) aOR 1.1 (0.3, 3.9) .9

Abbreviations: aOR, adjusted odds ratio; IV, intravenous.